Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
- PMID: 26650260
- PMCID: PMC4692767
- DOI: 10.3791/52402
Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
Abstract
Posterior Ischemic optic neuropathy (PION) is a sight-devastating disease in clinical practice. However, its pathogenesis and natural history have remained poorly understood. Recently, we developed a reliable, reproducible animal model of PION and tested the treatment effect of some neurotrophic factors in this model1. The purpose of this video is to demonstrate our photochemically induced model of posterior ischemic optic neuropathy, and to evaluate its effects with retrograde labeling of retinal ganglion cells. Following surgical exposure of the posterior optic nerve, a photosensitizing dye, erythrosin B, is intravenously injected and a laser beam is focused onto the optic nerve surface. Photochemical interaction of erythrosin B and the laser during irradiation damages the vascular endothelium, prompting microvascular occlusion mediated by platelet thrombosis and edematous compression. The resulting ischemic injury yields a gradual but pronounced retinal ganglion cell dieback, owing to a loss of axonal input - a remote, injury-induced and clinically relevant outcome. Thus, this model provides a novel platform to study the pathophysiologic course of PION, and can be further optimized for testing therapeutic approaches for optic neuropathies as well as other CNS ischemic diseases.
Similar articles
-
A novel rodent model of posterior ischemic optic neuropathy.JAMA Ophthalmol. 2013 Feb;131(2):194-204. doi: 10.1001/2013.jamaophthalmol.271. JAMA Ophthalmol. 2013. PMID: 23544206 Free PMC article.
-
Ischemic optic neuropathy.Prog Retin Eye Res. 2009 Jan;28(1):34-62. doi: 10.1016/j.preteyeres.2008.11.002. Epub 2008 Nov 27. Prog Retin Eye Res. 2009. PMID: 19063989 Review.
-
Severe, early axonal degeneration following experimental anterior ischemic optic neuropathy.Invest Ophthalmol Vis Sci. 2014 Sep 23;55(11):7111-8. doi: 10.1167/iovs.14-14603. Invest Ophthalmol Vis Sci. 2014. PMID: 25249599
-
Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION).Exp Eye Res. 2014 Jan;118:109-16. doi: 10.1016/j.exer.2013.11.012. Epub 2013 Dec 5. Exp Eye Res. 2014. PMID: 24316388
-
Axonal loss and neuroprotection in optic neuropathies.Can J Ophthalmol. 2007 Jun;42(3):403-8. Can J Ophthalmol. 2007. PMID: 17508035 Review.
Cited by
-
Matrix-bound nanovesicles prevent ischemia-induced retinal ganglion cell axon degeneration and death and preserve visual function.Sci Rep. 2019 Mar 5;9(1):3482. doi: 10.1038/s41598-019-39861-4. Sci Rep. 2019. PMID: 30837658 Free PMC article.
-
Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies.Pharmaceuticals (Basel). 2024 Sep 27;17(10):1281. doi: 10.3390/ph17101281. Pharmaceuticals (Basel). 2024. PMID: 39458922 Free PMC article. Review.
References
-
- Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004;17:27–35. - PubMed
-
- Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye (Lond) 2004;18:1188–1206. - PubMed
-
- Hayreh SS. Inter-Individual Variation in Blood-Supply of the Optic-Nerve Head. Doc Ophthalmol. 1985;59:217–246. - PubMed
-
- Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy - A case-control study of potential risk factors. Arch Ophthalmol-Chic. 1997;115:1403–1407. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources